These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 16779690

  • 1. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 2. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 3. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
    Kang JW, Kim JH, Ko GY, Gwon DI, Yoon HK, Sung KB.
    Acta Radiol; 2012 Jun 01; 53(5):545-50. PubMed ID: 22547388
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y, Balkanci F, Kayhan B, Uzunalimoglu B, Gokoz A, Ozisik Y, Gurakar A, Van Thiel DH, Firat D.
    Hepatogastroenterology; 1996 Jun 01; 43(9):681-7. PubMed ID: 8799415
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of variceal rebleeding and treatment of liver carcinoma by consecutive transjugular intrahepatic portosystemic shunt and hepatic artery chemoembolization.
    Nicolini A, Saccheri S, Lovaria A, Maggi A, Cazzaniga M, Panzeri A, Salerno F.
    Ital J Gastroenterol; 1996 Jun 01; 28(5):269-71. PubMed ID: 8842845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY.
    Cancer; 1997 Jun 01; 79(11):2087-94. PubMed ID: 9179054
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
    Ge NL, Ren ZG, Ye SL, Lin ZY, Xia JL, Gan YH, Li LX, Shen YF, Tang ZY.
    Zhonghua Zhong Liu Za Zhi; 2005 Jun 01; 27(6):380-2. PubMed ID: 16117905
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
    Cheng HY, Xu W, Xu AM, Chen D, Yang YF, Jia YC.
    Zhonghua Zhong Liu Za Zhi; 2005 Oct 01; 27(10):626-8. PubMed ID: 16438876
    [Abstract] [Full Text] [Related]

  • 14. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.
    J Nucl Med; 2009 Jun 01; 50(6):871-7. PubMed ID: 19443599
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ, Wu PH, Zhao M, Gu YK, Zhang L, Tan ZB.
    Zhonghua Zhong Liu Za Zhi; 2005 Apr 01; 27(4):248-50. PubMed ID: 15949431
    [Abstract] [Full Text] [Related]

  • 16. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S, Tanabe G, Nuruki K, Oketani M, Komorizono Y, Hokotate H, Fukukura Y, Baba Y, Imamura Y, Aikou T.
    J Hepatobiliary Pancreat Surg; 2002 Apr 01; 9(4):469-77. PubMed ID: 12483269
    [Abstract] [Full Text] [Related]

  • 17. [Transcatheter arterial chemo-embolization combined with CT-guided percutaneous intratumoral injection of lipiodol-ethanol for the treatment of primary hepatocellular carcinoma].
    Wu P, Li L, Zhang Y.
    Zhonghua Zhong Liu Za Zhi; 1998 Sep 01; 20(5):391-3. PubMed ID: 10921042
    [Abstract] [Full Text] [Related]

  • 18. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M, Suzuki H, Yamamoto T, Mamada Y, Mizuno H, Tominaga T, Suga M, Suemori S, Kato Y, Sato A, Yamanouchi E, Sakuyama K, Maeyama S, Shinagawa T, Okabe K.
    Semin Oncol; 1997 Apr 01; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [Abstract] [Full Text] [Related]

  • 19. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar 01; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 20. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y.
    Radiol Med; 2002 Mar 01; 104(5-6):412-20. PubMed ID: 12589262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.